Sensus Healthcare Inc
$ 3.07
3.02%
07 Aug - close price
- Market Cap 50,539,000 USD
- Current Price $ 3.07
- High / Low $ 3.07 / 2.96
- Stock P/E N/A
- Book Value 2.77
- EPS -0.47
- Next Earning Report 2026-08-13
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.13 %
- ROE -0.16 %
- 52 Week High 5.49
- 52 Week Low 2.66
About
Sensus Healthcare, Inc. manufactures, distributes and markets superficial radiation therapy devices to healthcare providers worldwide. The company is headquartered in Boca Raton, Florida.
Analyst Target Price
$5.75
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-07 | 2026-02-12 | 2025-11-06 | 2025-08-07 | 2025-05-15 | 2025-02-05 | 2024-11-14 | 2024-08-08 | 2024-05-09 | 2024-02-08 | 2023-11-09 | 2023-08-03 |
| Reported EPS | -0.16 | -0.19 | -0.06 | -0.06 | -0.16 | 0.09 | 0.07 | 0.1 | 0.14 | 0.26 | -0.09 | -0.02 |
| Estimated EPS | -0.11 | -0.05 | -0.11 | 0.01 | 0.04 | 0.12 | -0.01 | 0.03 | -0.04 | 0.14 | -0.02 | -0.08 |
| Surprise | -0.05 | -0.14 | 0.05 | -0.07 | -0.2 | -0.03 | 0.08 | 0.07 | 0.18 | 0.12 | -0.07 | 0.06 |
| Surprise Percentage | -45.4545% | -280% | 45.4545% | -700% | -500% | -25% | 800% | 233.3333% | 450% | 85.7143% | -350% | 75% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-13 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SRTS
2026-08-05 20:41:19
This article provides an earnings forecast for Sensus Healthcare Inc (SRTS), including its current earnings forecast score of 8.00 and an average price target of $8.00 based on 4 analysts. It details expected revenue for the next quarter at $4.60 million and an anticipated EPS of -$0.12. The analyst consensus indicates a "Buy" trend for the stock.
2026-08-01 06:11:05
Sensus Healthcare Inc (SRTS) has a current financial score of 6.52, ranking 148th in the Healthcare Equipment & Supplies industry, indicating robust financial status but low operating efficiency. Its latest quarterly revenue decreased by 59.32% year-over-year to $3.39M, and net profit saw a 2.10% year-over-year decrease. The article provides a detailed breakdown of financial health dimensions including Quality of Earnings, Operational Efficiency, Growth Potential, and Shareholder Returns, noting that relevant data for some sections have not been disclosed by the company.
2026-07-31 17:09:45
Sensus Healthcare (NASDAQ: SRTS) announced it will report its second quarter 2026 financial results on Thursday, August 13, 2026. The company will also host a conference call and webcast on the same day to discuss the results and provide a business update. Participants can access the call via phone or webcast.
2026-07-31 01:39:43
Sensus Healthcare Inc. (NASDAQ: SRTS) will announce its Q2 2026 financial results on August 13, 2026, followed by a business update conference call at 4:30 pm Eastern Time. Investors can register to receive a dial-in number or access the live webcast via the company's investor relations website. The call will cover key financial metrics, operational progress in superficial radiotherapy, and strategic updates.
2026-07-30 21:15:39
Sensus Healthcare, Inc. (Nasdaq: SRTS) will report its second quarter 2026 financial results on Thursday, August 13, 2026. The company will host a conference call and webcast at 4:30 PM Eastern time to discuss the results, provide a business update, and answer questions. Participants are encouraged to pre-register for the call.
2026-07-30 20:41:18
Sensus Healthcare, Inc. announced it will report its second-quarter 2026 financial results on Thursday, August 13, 2026. Management will host a conference call at 4:30 pm Eastern time to discuss the results, provide a business update, and answer questions. Participants can pre-register for the call or access it via dial-in numbers or a live webcast on the company's website.
